CHM CORE‑NK
Acute myeloid leukemia, other blood cancers, colorectal cancer
Phase 1bActive
Key Facts
Indication
Acute myeloid leukemia, other blood cancers, colorectal cancer
Phase
Phase 1b
Status
Active
Company
About Chimeric Therapeutics
Australian cell‑therapy pioneer advancing CAR‑T and NK‑cell cancer treatments in early clinical trials.
View full company profile